0001567619-18-004581.txt : 20181026
0001567619-18-004581.hdr.sgml : 20181026
20181026100730
ACCESSION NUMBER: 0001567619-18-004581
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20181026
DATE AS OF CHANGE: 20181026
EFFECTIVENESS DATE: 20181026
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: New Health Sciences, Inc.
CENTRAL INDEX KEY: 0001305849
IRS NUMBER: 522246819
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-304939
FILM NUMBER: 181140643
BUSINESS ADDRESS:
STREET 1: 6903 ROCKLEDGE DRIVE
STREET 2: SUITE 230
CITY: BETHESDA
STATE: MD
ZIP: 20817
BUSINESS PHONE: (301) 493-5550
MAIL ADDRESS:
STREET 1: 6903 ROCKLEDGE DRIVE
STREET 2: SUITE 230
CITY: BETHESDA
STATE: MD
ZIP: 20817
FORMER COMPANY:
FORMER CONFORMED NAME: New Health Sciences Inc
DATE OF NAME CHANGE: 20041014
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001305849
New Health Sciences, Inc.
99 Hayden Avenue
Building B, Suite 62
Lexington
MA
MASSACHUSETTS
02421
(617) 945-5079
DELAWARE
New Health Systems Inc.
New Health Sciences Inc
Corporation
true
Martin
A.
Cannon
99 Hayden Avenue
Building B, Suite 62
Lexington
MA
MASSACHUSETTS
02421
Executive Officer
Director
President, Chief Executive Officer and member of the Board of Directors
Guy
Cogan
99 Hayden Avenue
Building B, Suite 62
Lexington
MA
MASSACHUSETTS
02421
Director
Stephen
A.
Eckert
99 Hayden Avenue
Building B, Suite 62
Lexington
MA
MASSACHUSETTS
02421
Director
David
Herman
99 Hayden Avenue
Building B, Suite 62
Lexington
MA
MASSACHUSETTS
02421
Director
Richard
Perle
99 Hayden Avenue
Building B, Suite 62
Lexington
MA
MASSACHUSETTS
02421
Director
Michael
David
Testa
99 Hayden Avenue
Building B, Suite 62
Lexington
MA
MASSACHUSETTS
02421
Director
Joseph
Barrett
99 Hayden Avenue
Building B, Suite 62
Lexington
MA
MASSACHUSETTS
02421
Executive Officer
General Counsel and Secretary
Eric
Newman
99 Hayden Avenue
Building B, Suite 62
Lexington
MA
MASSACHUSETTS
02421
Executive Officer
Vice President and Chief Financial Officer
Biotechnology
Decline to Disclose
- 06b
true
0001140361-18-005339
2018-02-02
true
true
true
true
false
0
16000000
8750000
7250000
false
6
0
0
0
false
New Health Sciences, Inc.
/s/ Martin A. Cannon
Martin A. Cannon
President and Chief Executive Officer
2018-10-26